Grifols, S.A. develops, manufactures, and distributes plasma derivative products in the United States, Canada, Spain, rest of the European Union, and internationally. It specializes in providing infusion solutions, nutrition products, medical devices, diagnostic instrumentation, and reagents for use in hospitals and clinics. The company operates through four segments: Bioscience, Diagnostic, Hospital, and Raw Materials and Others. The company was founded in 1940 and is based in Barcelona, Spain.
The Plasma Fractionation market 2020 report includes thorough gathering of the quantitative analysis of the industry in order to assist players to grow in the market. Perceptions on specific revenue figures generated are also given in the report. This
Global Intravenous Immunoglobulin (IVIg) Market Synopsis: The Intravenous Immunoglobulin (IVIg) Market has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Intravenous Immunoglobulin (IVIg) market size to maintain the average annual growth rate of
DUBLIN--(BUSINESS WIRE)--The "Therapeutic Drug Monitoring Market by Product (Equipment (Immunoassay Analyzers), Consumables), Technology (Immunoassays, Chromatography-MS), Class of Drugs (Antibiotic Drugs, Bronchodilator Drugs), End User - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global therapeutic drug monitoring market is projected to reach USD 2.0 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.9% from 2020 to 2025. The growth of t
DUBLIN , Sept. 21, 2020 /PRNewswire/ -- The "Blood Collection Market by Product (Tubes (Plasma (EDTA, Heparin, Glucose), Serum), Blood Bags, Monitors, Needles), Method (Manual, Automated), Application (Diagnostic, Therapeutic), End User (Hospitals & ASCs, Blood Banks, Labs) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global blood collection devices market is projected to reach USD 6.47 billion by 2025 from USD 4.83 billion in 2020, at a CAGR of 6.0% between 2020 and 2025. The growth of this market is majorly driven by factors such as the increasing incidence of infectious diseases, the rising number of accidents & trauma cases, the emergence of liquid biopsy tests, and a demand for blood donations and blood components. However, complexities...